Monica Thomas
Human Resources Officer bij G1 THERAPEUTICS, INC.
Vermogen: 499 612 $ op 31-03-2024
Profiel
Monica Roberts Thomas is currently working as the General Counsel, Chief Legal & People Officer at G1 Therapeutics, Inc. Previously, she worked as the Head-Corporate Legal at Radius Health, Inc. She completed her undergraduate degree at Duke University and her graduate degree at NCCU School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0.22% | 20-03-2024 | 115 651 ( 0.22% ) | 499 612 $ | 31-03-2024 |
Actieve functies van Monica Thomas
| Bedrijven | Functie | Begin |
|---|---|---|
| G1 THERAPEUTICS, INC. | Human Resources Officer | - |
Eerdere bekende functies van Monica Thomas
| Bedrijven | Functie | Einde |
|---|---|---|
| RADIUS HEALTH, INC. | General Counsel | - |
Opleiding van Monica Thomas
| Duke University | Undergraduate Degree |
| NCCU School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
